André B Amon (@AndreAmonMD) header
André B Amon (@AndreAmonMD) profile picture

🫀 MD, MSc, Cardiology and Echocardiography

Porto Alegre, Brasil
Joined November 2022
Photo by André B Amon (@AndreAmonMD)Photo by André B Amon (@AndreAmonMD)Photo by André B Amon (@AndreAmonMD)Photo by André B Amon (@AndreAmonMD)Photo by André B Amon (@AndreAmonMD)Photo by André B Amon (@AndreAmonMD)Photo by André B Amon (@AndreAmonMD)Photo by André B Amon (@AndreAmonMD)
Our FASTEMI study is now published! 🎉 This quick and practical POCUS protocol in STEMI can be truly decisive: it guides management, identifies critical differential diagnoses, and achieves a 97% negative predictive value for in-hospital mortality. rdcu.be/eRSkX
9
24
4
45
11,092
André B Amon retweeted
> 600,000 left atrial appendage devices have been placed NOT NONINFERIOR 👇🏻 Trial is large, nonindustry funded and done in experienced centers in Germany Endpoint had both efficacy and safety components and still did not make non-inferiority I tried to tell you all
Among patients with atrial fibrillation at high risk for stroke and bleeding, left atrial appendage closure was not noninferior to medical therapy in reducing the risk of stroke, embolism, major bleeding, or death at 3 years. Full CLOSURE-AF trial results: nejm.org/doi/full/10.1056/NE… Editorial: Left Atrial Appendage Closure — Another Overused Method in Cardiology? nejm.org/doi/full/10.1056/NE…
41
126
11
531
202,516
André B Amon retweeted
Echo DD guidelines are consensus based and require testing to determine clinical utility. In this multicenter study with gold standard dx, we show poor sensitivity and accuracy for resting and exercise echo criteria. @JACCJournals jacc.org/doi/10.1016/j.jacc.…
7
47
6
124
46,241
Pleasure to collaborate with brilliant colleagues in Brazil on this important piece of work @saadi_marina @AndreAmonMD #POCUS #echofirst @guilhermehtelo
Our FASTEMI study is now published! 🎉 This quick and practical POCUS protocol in STEMI can be truly decisive: it guides management, identifies critical differential diagnoses, and achieves a 97% negative predictive value for in-hospital mortality. rdcu.be/eRSkX
2
10
18
5,101
André B Amon retweeted
LAAC vs best medical care Thrombotic events - higher Bleeding events -- higher (counting procedure; also see AVERROES) CV death -- higher (please don't dare tell me that it was noise because if you do, let's relook at PROTECT and PREVAIL LAAC done in experienced labs #AHA25
6
44
1
153
37,772
André B Amon retweeted
Here are my takeaways for the 7 most relevant and important #ESCCongress2025 for generalists AQUATIC, HI-PRO, RETREAT-FRAIL, DIGIT-HF, DAN-RSV were most practicing changing POTCAST was most contentious - not as billed
3
46
3
154
35,166
I think I have a positive bias toward the PARTHENOPE trial, not only because I was part of the Steering Committee and deeply respect the work behind it, but also because it does something rarely done when validating risk scores: randomization. Usually, we see validation based on discrimination or area under the curve, but in reality, the true test of a score’s utility is whether randomization to a score-guided versus non–score-guided strategy makes a difference on clinical outcomes. Just think of how many scores we use every day that lack this kind of validation. jacc.org/doi/10.1016/j.jacc.…
4
24
1
95
9,737
André B Amon retweeted
Dear #ESCCongress -- thx for such a great meeting. We all have a lot of work to do digging into all these trials. There are so many. Here are my first three: DIGIT HF medscape.com/viewarticle/fiv… REBOOT/BETAMI-DANBLOCK medscape.com/viewarticle/bet… REFINE ICD medscape.com/viewarticle/tim…
3
33
3
130
14,921
Today, I had the honor to present PhysioSync-HF as a Late-Breaking Clinical Trial at #ESCCongress. Key message: In HFrEF and LBBB, conduction system pacing was *inferior* to biventricular pacing for a composite of death, HF events, and LVEF change at 12 months.
6
35
2
154
23,825
📢¡¡¡Por fin un limite de Strain con valor pronóstico en "normales"!!! 📍Meta-análisis con 23,208 adultos confirma que el límite inferior normal del SGL es 16%. 📍Este valor puede tener relevancia pronóstica en pacientes asintomáticos con FEVI preservada bit.ly/4jB69iv
1
63
193
7,883
🚨 Just published! The LUV classification (LVOT-VTI + lung ultrasound) outperformed other ultrasound protocols in predicting in-hospital mortality and cardiogenic shock within 24h in STEMI patients link.springer.com/article/10…
1
4
7
689
First registry of TAVI in patients treated exclusively by the Brazilian Public Health System (SUS). An important data now that the procedure is being incorporated into SUS. journals.lww.com/critpathcar…
4
6
157
STEMI/OMI w/ peripheral embolization. #echofirst
3
149